期刊
PHARMACOGENOMICS
卷 11, 期 3, 页码 319-325出版社
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.09.158
关键词
adrenergic antagonist; genetics; GNB3; high blood pressure; pharmacogenomics; SNP
资金
- Italian Society of Hypertension (Fabuana Filigheddu)
- 'Associazione per to Sviluppo delta Ricerca sull'Ipertensione Arteriosa e sulle Malattie Cardiovascolari - ONLUS', Sassari, Italy
- Progetti di Educazione Sanitaria, Regione Sardegna, Italy
Aims: To analyze the association of haplotypes of the adrenergic system with essential hypertension and with the blood pressure response to beta-blockers. Materials & methods: In 1112 never-treated essential hypertension patients and 203 normotensive controls, tightly linked SNPs of beta-adrenergic receptors (ADRB1 - Ser49Gly and Arg389Gly; ADRB2 - Cys19Arg, Gly16Arg and GIn27Glu) and the G-protein beta 3-subunit (GNB3 - A3882C, G5249A and C825T) were genotyped. Association of haplotypes with essential hypertension and with the blood pressure response to atenolol 50 mg twice daily in a subgroup of essential hypertension patients (n = 340) was evaluated (Haploview 3.2). Results: No SNPs or haplotypes were associated with essential hypertension. In females only, GNB3 SNPs and haplotypes were associated with the blood pressure response (p < 0.05). Conclusion: Our study confirmed the sex-specific association of GNB3 with the blood pressure response to atenolol with no substantial advantage of the analysis of haplotypes over SNPs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据